phebra glucose 50% intravenous infusion 25g/50ml vial
phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.
salpac 3% iv infusion
orion infusion ltd. - sodium chloride - iv infusion - 3 gm/100 ml
fevac iv infusion
orion infusion ltd. - paracetamol - iv infusion - 1 gm/100 ml
precedex ready to use dexmedetomidine hydrochloride 400 micrograms/100 ml injection for intravenous infusion bottle
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
precedex ready to use dexmedetomidine hydrochloride 200 micrograms/50 ml injection for intravenous infusion bottle
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
precedex ready to use dexmedetomidine hydrochloride 80 micrograms/20 ml injection for intravenous infusion vial
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
chorionic gonadotropin for injection, usp powder for solution
fresenius kabi canada ltd - chorionic gonadotropin - powder for solution - 10000unit - chorionic gonadotropin 10000unit - gonadotropins and antigonadotropins
dexdor concentrate for solution for infusion 100 microgramsml
orion pharma (sg) pte. ltd. - dexmedetomidine hydrochloride eqv dexmedetomidine - infusion, solution concentrate - dexmedetomidine hydrochloride eqv dexmedetomidine 100 mcg/ml
proliv iv infusion
orion infusion ltd. - amino acids (essential) - iv infusion - 5 %
proliv plus iv infusion
orion infusion ltd. - amino acids (essential) + glucose & electrolytes - iv infusion - 7 % + 10 %